Related Experiment Video

Updated: Aug 12, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Novel approaches to lipid lowering: what is on the horizon?

W V Brown1

  • 1Emory University School of Medicine, Atlanta, Georgia, USA.

The American Journal of Cardiology
|March 21, 2001
PubMed

Insights

New lipid-lowering strategies are emerging, including novel agents and enhanced uses of existing treatments. Research is exploring additional reductions in low-density lipoprotein cholesterol (LDL-C) for improved cardiovascular disease prevention.

Area of Science:

  • Cardiovascular Medicine
  • Pharmacology
  • Lipid Metabolism

Background:

  • Lipid lowering is crucial for cardiovascular disease prevention.
  • Existing treatments are being re-evaluated for enhanced efficacy.
  • Novel therapeutic targets for lipid management are under investigation.

Purpose of the Study:

  • To review emerging strategies for lipid lowering.
  • To discuss the role of additional low-density lipoprotein cholesterol (LDL-C) reduction in cardiovascular prevention.
  • To highlight novel agents and combination therapies.

Main Methods:

  • Review of ongoing large-scale clinical trials.
  • Evaluation of new lipid-lowering drug classes.
  • Assessment of combination therapy approaches.

Main Results:

  • New statins with higher potency, like rosuvastatin, are in development.
  • Cholesterol absorption inhibitors (e.g., ezetimibe) show significant efficacy.
  • Acyl-CoA:cholesterol acyltransferase inhibitors (e.g., avasimibe) are being evaluated for reducing arterial lesion cholesterol.

Conclusions:

  • Novel agents and combination therapies offer promising new avenues for lipid management.
  • Further research is needed to confirm the benefits of intensive LDL-C reduction.
  • Personalized lipid-lowering strategies may improve cardiovascular outcomes.

More Related Videos

Lipidomics and Transcriptomics in Neurological Diseases09:58

Lipidomics and Transcriptomics in Neurological Diseases

Published on: March 18, 2022

Self-Nanoemulsification of Healthy Oils to Enhance the Solubility of Lipophilic Drugs08:18

Self-Nanoemulsification of Healthy Oils to Enhance the Solubility of Lipophilic Drugs

Published on: July 27, 2022

Related Concept Videos

What are Lipids?01:38

What are Lipids?

Overview
Lipid Digestion01:06

Lipid Digestion

Lipids are large molecules that are generally not water-soluble. Since most of the digestive enzymes in the human body are water-based, there are specific steps the body must take to break down lipids and make them available for use.
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Bioavailability Enhancement: Drug Permeability Enhancement01:27

Bioavailability Enhancement: Drug Permeability Enhancement

After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...